Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 185 articles:
HTML format



Single Articles


    August 2022
  1. MOHAMMADI-SHEMIRANI P, Chong M, Pare G
    Reply: Lipoprotein(a) and Atrial Fibrillation.
    J Am Coll Cardiol. 2022;80:e51.
    PubMed    


  2. HEGELE RA
    Lipoprotein(a) and Atrial Fibrillation.
    J Am Coll Cardiol. 2022;80:e49-e50.
    PubMed    


  3. SCHMIDT B, Chun KRJ
    Peridevice Leaks: The Plot Hole of Left Atrial Appendage Closure for Stroke Prophylaxis.
    J Am Coll Cardiol. 2022;80:484-485.
    PubMed    


  4. DUKKIPATI SR, Holmes DR Jr, Doshi SK, Kar S, et al
    Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure.
    J Am Coll Cardiol. 2022;80:469-483.
    PubMed     Abstract available


    July 2022
  5. SVENNBERG E
    How to Treat Patients With First-Diagnosed Atrial Fibrillation: The Less Clear Pattern?
    J Am Coll Cardiol. 2022;80:296-298.
    PubMed    


  6. GOETTE A, Borof K, Breithardt G, Camm AJ, et al
    Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy.
    J Am Coll Cardiol. 2022;80:283-295.
    PubMed     Abstract available


  7. DE BACKER J, Narula J
    Cardiolaminopathies: Weighing in on the Concept of Genotype-First Screening.
    J Am Coll Cardiol. 2022;80:60-62.
    PubMed    


  8. LAZARTE J, Jurgens SJ, Choi SH, Khurshid S, et al
    LMNA Variants and Risk of Adult-Onset Cardiac Disease.
    J Am Coll Cardiol. 2022;80:50-59.
    PubMed     Abstract available


  9. SOLOW EB, Bermas BL
    Hydroxychloroquine: Heart-Throb No More?
    J Am Coll Cardiol. 2022;80:47-49.
    PubMed    


    June 2022
  10. GAUDINO M, Di Franco A, Rong LQ, Cao D, et al
    Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:2529-2539.
    PubMed     Abstract available


  11. CURTIS AB, Korada SKC
    Should Atrial Fibrillation Be Included in Preoperative Risk Assessment for Noncardiac Surgery?
    J Am Coll Cardiol. 2022;79:2486-2488.
    PubMed    


  12. PRASADA S, Desai MY, Saad M, Smilowitz NR, et al
    Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery.
    J Am Coll Cardiol. 2022;79:2471-2485.
    PubMed     Abstract available


  13. AHMED A, Pothineni NVK, Charate R, Garg J, et al
    Inappropriate Sinus Tachycardia: Etiology, Pathophysiology, and Management: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:2450-2462.
    PubMed     Abstract available


  14. TAKAHASHI T, Samuels BA, Li W, Parikh MA, et al
    Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.
    J Am Coll Cardiol. 2022;79:2367-2378.
    PubMed     Abstract available


  15. AJOOLABADY A, Nattel S, Lip GYH, Ren J, et al
    Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:2349-2366.
    PubMed     Abstract available


    May 2022
  16. RAJPAL S, Kahwash R, Tong MS, Paschke K, et al
    Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways.
    J Am Coll Cardiol. 2022;79:2144-2152.
    PubMed     Abstract available


  17. CAMM AJ, Naccarelli GV, Mittal S, Crijns HJGM, et al
    The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:1932-1948.
    PubMed     Abstract available


  18. FREEMAN JV, Higgins AY, Wang Y, Du C, et al
    Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2022;79:1785-1798.
    PubMed     Abstract available


  19. HOLMES DR JR
    Antithrombotic Therapy After Left Atrial Appendage Occlusion: Cornucopia and Gertrude Stein.
    J Am Coll Cardiol. 2022;79:1799-1801.
    PubMed    


    April 2022
  20. KIM DS, Khandelwal A
    Lipoprotein(a) and Incident Atrial Fibrillation: Leveraging Nature's Randomization to Identify Novel Causal Associations.
    J Am Coll Cardiol. 2022;79:1591-1593.
    PubMed    


  21. MOHAMMADI-SHEMIRANI P, Chong M, Narula S, Perrot N, et al
    Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study.
    J Am Coll Cardiol. 2022;79:1579-1590.
    PubMed     Abstract available


  22. AMUTHAN R, Curtis AB
    Sex-Specific Considerations in Drug and Device Therapy of Cardiac Arrhythmias: JACC Focus Seminar 6/7.
    J Am Coll Cardiol. 2022;79:1519-1529.
    PubMed     Abstract available


  23. SALEEM M, Costanzo MR
    Survive VT: A Step Closer to "Smashing" Ischemic Ventricular Tachycardia?
    J Am Coll Cardiol. 2022;79:1454-1457.
    PubMed    


  24. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
    Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    J Am Coll Cardiol. 2022;79:1441-1453.
    PubMed     Abstract available


  25. PICCINI JP, Harrington J
    Midregional Pro-Atrial Natriuretic Peptide and Atrial Fibrillation: Interesting Association or Practice Changing?
    J Am Coll Cardiol. 2022;79:1382-1384.
    PubMed    


  26. SCHWEIZER J, Arnold M, Konig IR, Bicvic A, et al
    Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
    J Am Coll Cardiol. 2022;79:1369-1381.
    PubMed     Abstract available


    March 2022
  27. POWER DA, Lampert J, Camaj A, Bienstock SW, et al
    Cardiovascular Complications of Interatrial Conduction Block: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:1199-1211.
    PubMed     Abstract available


  28. FRIEDMAN DJ, Qin L, Parzynski C, Heist EK, et al
    Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients.
    J Am Coll Cardiol. 2022;79:1050-1059.
    PubMed     Abstract available


  29. MARWICK TH, Brugger N
    Effects of Atrial Fibrillation and Sinus Rhythm on Cardiac Remodeling and Valvular Regurgitation.
    J Am Coll Cardiol. 2022;79:962-964.
    PubMed    


  30. SOULAT-DUFOUR L, Lang S, Addetia K, Ederhy S, et al
    Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2022;79:951-961.
    PubMed     Abstract available


    February 2022
  31. ROMANOV A, Lomivorotov V, Chernyavskiy A, Murtazin V, et al
    Temporary Spinal Cord Stimulation to Prevent Postcardiac Surgery Atrial Fibrillation: 30-Day Safety and Efficacy Outcomes.
    J Am Coll Cardiol. 2022;79:754-756.
    PubMed    


  32. ZAFEIROPOULOS S, Doundoulakis I, Farmakis IT, Miyara S, et al
    Autonomic Neuromodulation for Atrial Fibrillation Following Cardiac Surgery: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:682-694.
    PubMed     Abstract available


  33. LEYVA F, Zegard A, Okafor O, Foley P, et al
    Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device Implantation.
    J Am Coll Cardiol. 2022;79:665-678.
    PubMed     Abstract available


  34. VRANCKX P, Angiolillo DJ, Valgimigli M
    Patients With Atrial Fibrillation and PCI or ACS: Does Predicted Risk Matter?
    J Am Coll Cardiol. 2022;79:428-431.
    PubMed    


  35. HARSKAMP RE, Fanaroff AC, Lopes RD, Wojdyla DM, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
    J Am Coll Cardiol. 2022;79:417-427.
    PubMed     Abstract available


    January 2022
  36. VOLGMAN AS, Nair G, Lyubarova R, Merchant FM, et al
    Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:166-179.
    PubMed     Abstract available


  37. MERCHANT FM
    Does Percutaneous Left Atrial Appendage Closure Stand the Test of Time?
    J Am Coll Cardiol. 2022;79:15-17.
    PubMed    


    December 2021
  38. NORBY FL, Benjamin EJ, Alonso A, Chugh SS, et al
    Racial and Ethnic Considerations in Patients With Atrial Fibrillation: JACC Focus Seminar 5/9.
    J Am Coll Cardiol. 2021;78:2563-2572.
    PubMed     Abstract available


  39. SALMASI S, De Vera MA, Safari A, Lynd LD, et al
    Longitudinal Oral Anticoagulant Adherence Trajectories in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2021;78:2395-2404.
    PubMed     Abstract available


  40. SAHA SA
    Premature Ventricular Complexes During Exercise in Asymptomatic Adults: Do They Deserve a Closer Look?
    J Am Coll Cardiol. 2021;78:2278-2280.
    PubMed    


  41. REFAAT MM, Gharios C, Moorthy MV, Abdulhai F, et al
    Exercise-Induced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals.
    J Am Coll Cardiol. 2021;78:2267-2277.
    PubMed     Abstract available


    November 2021
  42. MARQUEZ MF
    The Quest for the Evidence of Effectiveness of Implantable Cardioverter-Defibrillators in Long QT Syndrome.
    J Am Coll Cardiol. 2021;78:2089-2091.
    PubMed    


  43. WANG M, Peterson DR, Rosero S, McNitt S, et al
    Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2021;78:2076-2088.
    PubMed     Abstract available


  44. TERTULIEN T, Magnani JW, Essien UR
    Racial and Ethnic Representation in Atrial Fibrillation Trials: CABANA and Beyond.
    J Am Coll Cardiol. 2021;78:e163-e164.
    PubMed    


  45. SIMARD T, Jung RG, Hibbert B, Holmes DR Jr, et al
    Reply: Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
    J Am Coll Cardiol. 2021;78:e159.
    PubMed    


  46. WANG X, Wang P, Pei H
    Left Atrial Appendage Occlusion in Hypertrophic Cardiomyopathy Patients Should Be Taken Into Account.
    J Am Coll Cardiol. 2021;78:e157.
    PubMed    


    October 2021
  47. OSMANCIK P, Herman D, Neuzil P, Hala P, et al
    Left Atrial Appendage Closure versus Non-Warfarin Oral Anticoagulation in Atrial Fibrillation: 4-Year Outcomes of PRAGUE-17.
    J Am Coll Cardiol. 2021 Oct 27. pii: S0735-1097(21)07895.
    PubMed     Abstract available


  48. ERNAULT AC, Meijborg VMF, Coronel R
    Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:1730-1745.
    PubMed     Abstract available


  49. ESCOBAR-LOPEZ L, Ochoa JP, Mirelis JG, Espinosa MA, et al
    Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2021;78:1682-1699.
    PubMed     Abstract available


  50. BEHR ER
    J-Wave Syndromes, SCN5A, and Cardiac Conduction Reserve: Two Sides of the Same Coin?
    J Am Coll Cardiol. 2021;78:1618-1620.
    PubMed    


  51. ZHANG ZH, Barajas-Martinez H, Xia H, Li B, et al
    Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
    J Am Coll Cardiol. 2021;78:1603-1617.
    PubMed     Abstract available


  52. ASATRYAN B, Odening KE, Reichlin T
    Myocardial Histopathology Studies in Brugada Syndrome Decedents: Structural Features of a Presumed Electrical Disease.
    J Am Coll Cardiol. 2021;78:1522-1524.
    PubMed    


  53. MILES C, Asimaki A, Ster IC, Papadakis M, et al
    Biventricular Myocardial Fibrosis and Sudden Death in Patients With Brugada Syndrome.
    J Am Coll Cardiol. 2021;78:1511-1521.
    PubMed     Abstract available


    September 2021
  54. LURIE A, Wang J, Healey JS, Wong JA, et al
    Reply: Effects of Cardiac Amyloidosis and Screening Approach on Left Atrial Thrombus Prevalence in Atrial Fibrillation.
    J Am Coll Cardiol. 2021;78:e91-e92.
    PubMed    


  55. KADISH A, Jacobson J
    Sleep Patterns and Arrhythmias: Should This Keep Us Awake at Night?
    J Am Coll Cardiol. 2021;78:1208-1209.
    PubMed    


  56. LI X, Zhou T, Ma H, Huang T, et al
    Healthy Sleep Patterns and Risk of Incident Arrhythmias.
    J Am Coll Cardiol. 2021;78:1197-1207.
    PubMed     Abstract available


    August 2021
  57. ANDRADE JG, Wazni OM, Kuniss M, Hawkins NM, et al
    Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:914-930.
    PubMed     Abstract available


  58. CASAS G, Limeres J, Oristrell G, Gutierrez-Garcia L, et al
    Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.
    J Am Coll Cardiol. 2021;78:643-662.
    PubMed     Abstract available


  59. BERG DD, Giugliano RP, Ruff CT, Tang M, et al
    A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48.
    J Am Coll Cardiol. 2021;78:634-636.
    PubMed    


    July 2021
  60. WAZNI O, Saliba W, Hussein AA
    Device-Related Thrombus After Left Atrial Appendage Occlusion.
    J Am Coll Cardiol. 2021;78:314-316.
    PubMed    


  61. SIMARD T, Jung RG, Lehenbauer K, Piayda K, et al
    Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.
    J Am Coll Cardiol. 2021;78:297-313.
    PubMed     Abstract available


  62. THOMAS KL, Al-Khalidi HR, Silverstein AP, Monahan KH, et al
    Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.
    J Am Coll Cardiol. 2021;78:126-138.
    PubMed     Abstract available


  63. RUSSO AM
    Catheter Ablation Is Better Than Drugs for Treatment of AF in Racial and Ethnic Minorities.
    J Am Coll Cardiol. 2021;78:139-141.
    PubMed    


    June 2021
  64. GRANGER CB, Pokorney SD
    Preventing and Managing Bleeding With Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:3002-3004.
    PubMed    


  65. DI MARCO A, Brown PF, Bradley J, Nucifora G, et al
    Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2021;77:2890-2905.
    PubMed     Abstract available


  66. LURIE A, Wang J, Hinnegan KJ, McIntyre WF, et al
    Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:2875-2886.
    PubMed     Abstract available


  67. KIRCHHOF P, Sinning C
    Thrombus or No Thrombus: Is That the Embolic Question?
    J Am Coll Cardiol. 2021;77:2887-2889.
    PubMed    


  68. CHEN YC, Voskoboinik A, Gerche A, Marwick TH, et al
    Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2846-2864.
    PubMed     Abstract available


  69. TREVISAN F, Bertini M, Balla C, Pestelli G, et al
    Type 1 Brugada Pattern Is Associated With Echocardiography-Detected Delayed Right Ventricular Outflow Tract Contraction.
    J Am Coll Cardiol. 2021;77:2865-2867.
    PubMed    


  70. RAO VU, Reeves DJ, Chugh AR, O'Quinn R, et al
    Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2693-2716.
    PubMed     Abstract available


    May 2021
  71. TOBERT KE, Bos JM, Garmany R, Ackerman MJ, et al
    Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death.
    J Am Coll Cardiol. 2021 May 26. pii: S0735-1097(21)04779.
    PubMed     Abstract available


  72. AKTAS MK, Younis A, Zareba W, Kutyifa V, et al
    Survival After Implantable Cardioverter-Defibrillator Shocks.
    J Am Coll Cardiol. 2021;77:2453-2462.
    PubMed     Abstract available


  73. DEO R, Pothineni NVK
    The "Shocking" Reality of ICD Therapies.
    J Am Coll Cardiol. 2021;77:2463-2465.
    PubMed    


  74. CHRISTENSEN AH, Nyholm BC, Vissing CR, Pietersen A, et al
    Natural History and Clinical Characteristics of the First 10 Danish Families With Familial ST-Depression Syndrome.
    J Am Coll Cardiol. 2021;77:2617-2619.
    PubMed    


  75. PRIORI SG, Mazzanti A, Santiago DJ, Kukavica D, et al
    Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5.
    J Am Coll Cardiol. 2021;77:2592-2612.
    PubMed     Abstract available


  76. GIUDICESSI JR, Ackerman MJ, Fatkin D, Kovacic JC, et al
    Precision Medicine Approaches to Cardiac Arrhythmias: JACC Focus Seminar 4/5.
    J Am Coll Cardiol. 2021;77:2573-2591.
    PubMed     Abstract available


  77. NACCARELLI GV, Filippone EJ, Foy A
    Do Mineralcorticoid Receptor Antagonists Suppress Atrial Fibrillation/Flutter?
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04967.
    PubMed    


  78. FILIPPATOS G, Bakris GL, Pitt B, Agarwal R, et al
    Finerenone Reduces Onset of Atrial Fibrillation in Patients with Chronic Kidney Disease and Type 2 Diabetes.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04966.
    PubMed     Abstract available


    April 2021
  79. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
    Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
    J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
    PubMed    


    March 2021
  80. MUNTANE-CAROL G, Philippon F, Nault I, Faroux L, et al
    Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:1344-1356.
    PubMed     Abstract available


  81. ROMERO J, Velasco A, Pisani CF, Alviz I, et al
    Advanced Therapies for Ventricular Arrhythmias in Patients With Chagasic Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:1225-1242.
    PubMed     Abstract available


  82. HALPERIN JL, Rashed ER
    Low-Dose Anticoagulation for Atrial Fibrillation: When Is a Floor a Trap Door?
    J Am Coll Cardiol. 2021;77:1208-1210.
    PubMed    


  83. STEFFEL J, Ruff CT, Yin O, Braunwald E, et al
    Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:1197-1207.
    PubMed     Abstract available


  84. CALO L, Della Bona R, Martino A, Crescenzi C, et al
    Left Posterior Fascicular Block and Increased Risk of Sudden Cardiac Death in Young People.
    J Am Coll Cardiol. 2021;77:1143-1145.
    PubMed    


    February 2021
  85. ZEITLER EP, Piccini JP
    Pre-Diabetes and Stroke in Patients With Atrial Fibrillation: When Risk Begets Risk.
    J Am Coll Cardiol. 2021;77:885-887.
    PubMed    


  86. KEZERLE L, Tsadok MA, Akriv A, Senderey AB, et al
    Pre-Diabetes Increases Stroke Risk in Patients With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:875-884.
    PubMed     Abstract available


  87. LYON AR, Citro R, Schneider B, Morel O, et al
    Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:902-921.
    PubMed     Abstract available


  88. COHEN MI, Khairy P, Zeppenfeld K, Van Hare GF, et al
    Preventing Arrhythmic Death in Patients With Tetralogy of Fallot: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:761-771.
    PubMed     Abstract available


    January 2021
  89. ALEXANDER JH
    Preventing Atrial Fibrillation After Cardiac Surgery: What Matters Most.
    J Am Coll Cardiol. 2021;77:68-70.
    PubMed    


  90. WANG H, Zhang Y, Xin F, Jiang H, et al
    Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation.
    J Am Coll Cardiol. 2021;77:57-67.
    PubMed     Abstract available


  91. ARAI AE, Bradley AJ, Sirajuddin A
    Risk Stratification for Sudden Death and Arrhythmias: A Role for Gadolinium-Enhanced CMR.
    J Am Coll Cardiol. 2021;77:42-44.
    PubMed    


  92. ZEGARD A, Okafor O, de Bono J, Kalla M, et al
    Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease.
    J Am Coll Cardiol. 2021;77:29-41.
    PubMed     Abstract available


    December 2020
  93. REDDY VY, Neuzil P, Anic A
    Reply: Pulsed Field Ablation for Persistent Atrial Fibrillation: Do Electrophysiological Endpoints Predict Clinical Benefit?
    J Am Coll Cardiol. 2020;76:3065-3066.
    PubMed    


  94. FUTYMA P, Kulakowski P
    Pulsed Field Ablation for Persistent Atrial Fibrillation: Do Electrophysiological Endpoints Predict Clinical Benefit?
    J Am Coll Cardiol. 2020;76:3064-3065.
    PubMed    


  95. EL-ESHMAWI A, Pandis D, Miller MA, Boateng P, et al
    Surgical Cryoablation of Papillary Muscle PVCs During Mitral Valve Surgery: Therapeutic Consideration for Malignant MVP.
    J Am Coll Cardiol. 2020;76:3061-3062.
    PubMed    


  96. FAXEN J, Jernberg T, Hollenberg J, Gadler F, et al
    Incidence and Predictors of Out-of-Hospital Cardiac Arrest Within 90 Days After Myocardial Infarction.
    J Am Coll Cardiol. 2020;76:2926-2936.
    PubMed     Abstract available


  97. MARWICK TH
    Echocardiography in Long QT Syndrome: The Mechanical Face of an Electrical Disease.
    J Am Coll Cardiol. 2020;76:2844-2846.
    PubMed    


  98. SUGRUE A, van Zyl M, Enger N, Mancl K, et al
    Echocardiography-Guided Risk Stratification for Long QT Syndrome.
    J Am Coll Cardiol. 2020;76:2834-2843.
    PubMed     Abstract available


  99. BHAGIRATH VC, Chan N, Hirsh J, Ginsberg J, et al
    Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose.
    J Am Coll Cardiol. 2020;76:2906-2907.
    PubMed    


  100. TURAGAM MK, Osmancik P, Neuzil P, Dukkipati SR, et al
    Left Atrial Appendage Closure Versus Oral Anticoagulants in Atrial Fibrillation: A Meta-Analysis of Randomized Trials.
    J Am Coll Cardiol. 2020;76:2795-2797.
    PubMed    


  101. HEIDENREICH PA, Estes NAM 3rd, Fonarow GC, Jurgens CY, et al
    2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2020 Dec 1. pii: S0735-1097(20)36400.
    PubMed    


    November 2020
  102. KUMBHANI DJ, Cannon CP, Beavers CJ, Bhatt DL, et al
    2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report
    J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)36615.
    PubMed    


  103. NATTEL S, Guichard JB
    Reply: Could Different Thresholds for Tachycardic-Induced Atrial Myopathy Reflect Different Rates Between Atrial Fibrillation and Flutter?
    J Am Coll Cardiol. 2020;76:2179-2180.
    PubMed    


  104. REIFFEL JA
    Could Different Thresholds for Tachycardic-Induced Atrial Myopathy Reflect Different Rates Between Atrial Fibrillation and Flutter?
    J Am Coll Cardiol. 2020;76:2179.
    PubMed    


    October 2020
  105. KOSUGI S, Shinouchi K, Ueda Y, Abe H, et al
    Clinical and Angiographic Features of Patients With Out-of-Hospital Cardiac Arrest and Acute Myocardial Infarction.
    J Am Coll Cardiol. 2020;76:1934-1943.
    PubMed     Abstract available


  106. CHAN YH, Chao TF, Lee HF, Yeh YH, et al
    Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes.
    J Am Coll Cardiol. 2020;76:1808-1810.
    PubMed    


  107. SHIVKUMAR K, Do DH
    Catheter Ablation of Ventricular Tachycardia: First, Treat the Underlying Disease.
    J Am Coll Cardiol. 2020;76:1657-1659.
    PubMed    


  108. PERETTO G, Sala S, Basso C, Rizzo S, et al
    Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis.
    J Am Coll Cardiol. 2020;76:1644-1656.
    PubMed     Abstract available


    September 2020
  109. CAMM AJ, Cools F, Virdone S, Bassand JP, et al
    Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.
    J Am Coll Cardiol. 2020;76:1425-1436.
    PubMed     Abstract available


  110. NACCARELLI GV
    Direct Oral Anticoagulant Dosing: Truth or Consequences.
    J Am Coll Cardiol. 2020;76:1437-1439.
    PubMed    


  111. VARMA N, Marrouche NF, Aguinaga L, Albert CM, et al
    HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic.
    J Am Coll Cardiol. 2020;76:1363-1374.
    PubMed    


  112. NALLIAH CJ, Bell JR, Raaijmakers AJA, Waddell HM, et al
    Epicardial Adipose Tissue Accumulation Confers Atrial Conduction Abnormality.
    J Am Coll Cardiol. 2020;76:1197-1211.
    PubMed     Abstract available


  113. TOMLINSON DR, Mandrola J
    Pulsed Field Ablation for Persistent Atrial Fibrillation (PersAFOne): Hope or Hype?
    J Am Coll Cardiol. 2020;76:1081-1083.
    PubMed    


  114. REDDY VY, Anic A, Koruth J, Petru J, et al
    Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:1068-1080.
    PubMed     Abstract available


  115. KOSMALA W
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: How to Fight Allied Enemies.
    J Am Coll Cardiol. 2020;76:1065-1067.
    PubMed    


  116. REDDY YNV, Obokata M, Verbrugge FH, Lin G, et al
    Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:1051-1064.
    PubMed     Abstract available


    August 2020
  117. AMELOOT K, Jakkula P, Hastbacka J, Reinikainen M, et al
    Optimum Blood Pressure in Patients With Shock After Acute Myocardial Infarction and Cardiac Arrest.
    J Am Coll Cardiol. 2020;76:812-824.
    PubMed     Abstract available


  118. YAFASOVA A, Fosbol EL, Schou M, Gustafsson F, et al
    Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
    J Am Coll Cardiol. 2020;76:767-777.
    PubMed     Abstract available


  119. GARBI M, Garweg C
    Arrhythmia in Mitral Valve Prolapse: All Roads Lead to Rome.
    J Am Coll Cardiol. 2020;76:650-652.
    PubMed    


  120. ESSAYAGH B, Sabbag A, Antoine C, Benfari G, et al
    Presentation and Outcome of Arrhythmic Mitral Valve Prolapse.
    J Am Coll Cardiol. 2020;76:637-649.
    PubMed     Abstract available


  121. BRABRAND M, Jensen HK, Ekelund U, Forberg JL, et al
    QTc Interval Prolongation Is a Proxy for Increased Short-Term Mortality.
    J Am Coll Cardiol. 2020;76:630-631.
    PubMed    


  122. TOMASELLI GF, Mahaffey KW, Cuker A, Dobesh PP, et al
    2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2020;76:594-622.
    PubMed    


    July 2020
  123. NAZARI MA, Rosenblum JS, Haigney MC, Rosing DR, et al
    Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:451-464.
    PubMed     Abstract available


  124. POOLE JE, Olshansky B, Mark DB, Anderson J, et al
    Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
    J Am Coll Cardiol. 2020;76:405-415.
    PubMed     Abstract available


  125. CALKINS H
    Important Differences Exist Between Atrial Fibrillation and Atrial Flutter in Atrial Remodeling.
    J Am Coll Cardiol. 2020;76:389-390.
    PubMed    


  126. GUICHARD JB, Naud P, Xiong F, Qi X, et al
    Comparison of Atrial Remodeling Caused by Sustained Atrial Flutter Versus Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:374-388.
    PubMed     Abstract available


  127. RWEBEMBERA J, Jeilan M, Ajijola OA, Talle M, et al
    Cardiac Pacing Training in Africa: Endorsed by the Africa Heart Rhythm Association (AFHRA): JACC International.
    J Am Coll Cardiol. 2020;76:465-472.
    PubMed     Abstract available


  128. POKORNEY SD, Black-Maier E, Piccini JP
    Reply: Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    J Am Coll Cardiol. 2020;76:351-352.
    PubMed    


  129. ILYAS I, Doshi R
    The Difficult Balance of Oral Anticoagulation in Patients With End-Stage Renal Disease.
    J Am Coll Cardiol. 2020;76:350-351.
    PubMed    


  130. BURLACU A, Covic A
    The Devil Is in the Details When Considering the OAC Efficacy-Safety Equation in Dialysis Patients.
    J Am Coll Cardiol. 2020;76:349-350.
    PubMed    


  131. STRASBURGER JF, Wacker-Gussmann A
    Congenital Heart Block in Subsequent Pregnancies of SSA/Ro-Positive Mothers: Cutting Recurrence in Half.
    J Am Coll Cardiol. 2020;76:303-305.
    PubMed    


  132. IZMIRLY P, Kim M, Friedman DM, Costedoat-Chalumeau N, et al
    Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
    J Am Coll Cardiol. 2020;76:292-302.
    PubMed     Abstract available


  133. JAAKKOLA S, Nuotio I, Hartikainen JEK, Airaksinen KEJ, et al
    Early Cardioversion for Acute Atrial Fibrillation in Low Stroke Risk Patients Is Safe Without Anticoagulation.
    J Am Coll Cardiol. 2020;76:226-227.
    PubMed    


  134. PERETTO G, Sala S, Della Bella P, Basso C, et al
    Reply: Genetic Basis for Acute Myocarditis Presenting With Ventricular Arrhythmias?
    J Am Coll Cardiol. 2020;76:126-128.
    PubMed    


  135. KALRA R, Nijjar PS
    Genetic Basis for Acute Myocarditis Presenting With Ventricular Arrhythmias?
    J Am Coll Cardiol. 2020;76:126.
    PubMed    


    June 2020
  136. OSMANCIK P, Herman D, Neuzil P, Hala P, et al
    Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:3122-3135.
    PubMed     Abstract available


  137. POOLE JE, Bahnson TD, Monahan KH, Johnson G, et al
    Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
    J Am Coll Cardiol. 2020;75:3105-3118.
    PubMed     Abstract available


  138. GOLLOB MH
    COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm.
    J Am Coll Cardiol. 2020;75:3184-3186.
    PubMed    


  139. PRICE MJ, Saw J
    Transcatheter Left Atrial Appendage Occlusion in the DOAC Era.
    J Am Coll Cardiol. 2020;75:3136-3139.
    PubMed    


  140. MARCHLINSKI FE, Walsh K, Guandalini GS
    Reporting AF Recurrence After Catheter Ablation: The Burden Is on Us to Get it Right.
    J Am Coll Cardiol. 2020;75:3119-3121.
    PubMed    


  141. CHANG D, Saleh M, Gabriels J, Ismail H, et al
    Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin.
    J Am Coll Cardiol. 2020;75:2992-2993.
    PubMed    


  142. BLUEMKE DA, James CA, Te Riele ASJM
    Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Not a One-Size-Fits-All Strategy.
    J Am Coll Cardiol. 2020;75:2766-2768.
    PubMed    


  143. AQUARO GD, De Luca A, Cappelletto C, Raimondi F, et al
    Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2020;75:2753-2765.
    PubMed     Abstract available


  144. KHALID U, Marzec LN, Mantini N, Manson SM, et al
    Treatment of AF in American Indians and Alaska Natives: Insights From the NCDR PINNACLE-AF Registry.
    J Am Coll Cardiol. 2020;75:2749-2750.
    PubMed    


    May 2020
  145. RODEN DM, Harrington RA, Poppas A, Russo AM, et al
    Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.
    J Am Coll Cardiol. 2020;75:2623-2624.
    PubMed    


  146. BOUTJDIR M, Lazzerini PE
    A Novel Peptide/Antibody-Based Antiarrhythmic Approach to Long QT Syndrome and Beyond.
    J Am Coll Cardiol. 2020;75:2153-2155.
    PubMed    


  147. MAGUY A, Kucera JP, Wepfer JP, Forest V, et al
    KCNQ1 Antibodies for Immunotherapy of Long QT Syndrome Type 2.
    J Am Coll Cardiol. 2020;75:2140-2152.
    PubMed     Abstract available


    April 2020
  148. ACKERMAN MJ, Giudicessi JR
    Time to Redefine the Natural History and Clinical Management of Type 1 Andersen-Tawil Syndrome?
    J Am Coll Cardiol. 2020;75:1785-1787.
    PubMed    


  149. MAZZANTI A, Guz D, Trancuccio A, Pagan E, et al
    Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
    J Am Coll Cardiol. 2020;75:1772-1784.
    PubMed     Abstract available


  150. GALLI M, Andreotti F, D'Amario D, Porto I, et al
    Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI Trials.
    J Am Coll Cardiol. 2020;75:1727-1728.
    PubMed    


  151. MADIAS C, Parzynski CS, Burrows A, Minges KE, et al
    Utilization Effects of the Affordable Care Act on Implantable Cardioverter-Defibrillator Therapy.
    J Am Coll Cardiol. 2020;75:1714-1717.
    PubMed    


  152. CHUNG MK, Refaat M, Shen WK, Kutyifa V, et al
    Atrial Fibrillation: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;75:1689-1713.
    PubMed     Abstract available


  153. RUFF CT
    The Promise of Mobile Health in Managing Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1535-1537.
    PubMed    


  154. GUO Y, Lane DA, Wang L, Zhang H, et al
    Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1523-1534.
    PubMed     Abstract available


  155. LAKKIREDDY DR, Turagam MK
    NCDR Left Atrial Appendage Occlusion Registry: The "Watch" Man Has Arrived.
    J Am Coll Cardiol. 2020;75:1519-1522.
    PubMed    


  156. SANA F, Isselbacher EM, Singh JP, Heist EK, et al
    Wearable Devices for Ambulatory Cardiac Monitoring: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2020;75:1582-1592.
    PubMed     Abstract available


  157. FREEMAN JV, Varosy P, Price MJ, Slotwiner D, et al
    The NCDR Left Atrial Appendage Occlusion Registry.
    J Am Coll Cardiol. 2020;75:1503-1518.
    PubMed     Abstract available


    March 2020
  158. STEVENSON LW, Naftilan AJ
    Changing the Stage Directions for Heart Failure?
    J Am Coll Cardiol. 2020;75:1439-1442.
    PubMed    


  159. OLESEN JB, Bonde AN
    When Oral Anticoagulation Becomes Difficult.
    J Am Coll Cardiol. 2020;75:1309-1310.
    PubMed    


  160. BENSON L, Horlick E, Osten M
    Percutaneous Repair of the Sinus Venosus Atrial Defect: Usus Est Magister Optimus.
    J Am Coll Cardiol. 2020;75:1279-1280.
    PubMed    


  161. DRIGGIN E, Madhavan MV, Bikdeli B, Chuich T, et al
    Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    J Am Coll Cardiol. 2020 Mar 18. pii: S0735-1097(20)34637.
    PubMed     Abstract available


  162. REYNOLDS MR, Kramer DB, Yeh RW, Cohen DJ, et al
    AF Ablation Outcomes: Real World or Fun House Mirror?
    J Am Coll Cardiol. 2020;75:1243.
    PubMed    


  163. KHO C
    Can Patient Pluripotent Stem Cell-Derived Cardiomyocytes Provide Useful Modeling on Arrhythmias of DMD Cardiomyopathy?
    J Am Coll Cardiol. 2020;75:1175-1177.
    PubMed    


  164. ZEITOUNI M, Giczewska A, Lopes RD, Wojdyla DM, et al
    Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial.
    J Am Coll Cardiol. 2020;75:1145-1155.
    PubMed     Abstract available


  165. BINDING C, Olesen JB, Bonde AN
    Reply: Anticoagulant Therapy and Hip Fracture Risk: A Possible Involvement of Physical Activity.
    J Am Coll Cardiol. 2020;75:987-988.
    PubMed    


  166. SUGIYAMA T
    Anticoagulant Therapy and Hip Fracture Risk: A Possible Involvement of Physical Activity.
    J Am Coll Cardiol. 2020;75:987.
    PubMed    


  167. STEVENSON WG, Richardson TD, Kanagasundram A
    Ventricular Tachycardia in 3 Dimensions.
    J Am Coll Cardiol. 2020;75:898-900.
    PubMed    


  168. TUNG R, Raiman M, Liao H, Zhan X, et al
    Simultaneous Endocardial and Epicardial Delineation of 3D Reentrant Ventricular Tachycardia.
    J Am Coll Cardiol. 2020;75:884-897.
    PubMed     Abstract available


    February 2020
  169. VIJAYARAMAN P, Nayak HM, Ellenbogen KA
    Left Ventricular Septal Versus Left Bundle Branch Pacing: A New Beginning in Cardiac Resynchronization Therapy?
    J Am Coll Cardiol. 2020;75:360-362.
    PubMed    


  170. SALDEN FCWM, Luermans JGLM, Westra SW, Weijs B, et al
    Short-Term Hemodynamic and Electrophysiological Effects of Cardiac Resynchronization by Left Ventricular Septal Pacing.
    J Am Coll Cardiol. 2020;75:347-359.
    PubMed     Abstract available


    January 2020
  171. BISBAL F, Baranchuk A, Braunwald E, Bayes de Luna A, et al
    Atrial Failure as a Clinical Entity: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:222-232.
    PubMed     Abstract available


  172. PAGANO G, Cannavo A, Rengo G
    Is the Hitman in Cardiac Death Hidden in the Sympathetic Nervous System Remodeling?
    J Am Coll Cardiol. 2020;75:14-16.
    PubMed    


  173. DI BIASE L, Mohanty S, Romero J, Della Rocca DG, et al
    Reply: LAA Electrical Isolation: A Tool to Achieve Superior Ablation Success Under Protection of Optimal Anticoagulation.
    J Am Coll Cardiol. 2020;75:130-131.
    PubMed    


  174. ADELINO R, Bazan V, Villuendas R, Bisbal F, et al
    Left Atrial Appendage Isolation and Preserved Function: Is it Really Isolated?
    J Am Coll Cardiol. 2020;75:129-130.
    PubMed    


  175. TAN AY, Elharrif K, Cardona-Guarache R, Mankad P, et al
    Persistent Proarrhythmic Neural Remodeling Despite Recovery From Premature Ventricular Contraction-Induced Cardiomyopathy.
    J Am Coll Cardiol. 2020;75:1-13.
    PubMed     Abstract available


    November 2019
  176. OBOKATA M, Reddy YNV, Shah SJ, Kaye DM, et al
    Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:2539-2550.
    PubMed     Abstract available


    August 2019
  177. RODES-CABAU J, Ellenbogen KA, Krahn AD, Latib A, et al
    Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel.
    J Am Coll Cardiol. 2019;74:1086-1106.
    PubMed     Abstract available


  178. DESHAIES C, Hamilton RM, Shohoudi A, Trottier H, et al
    Thromboembolic Risk After Atriopulmonary, Lateral Tunnel, and Extracardiac Conduit Fontan Surgery.
    J Am Coll Cardiol. 2019;74:1071-1081.
    PubMed     Abstract available


  179. ZOGHBI WA
    Should Left Atrial Size Influence the Decision to Intervene in Degenerative Mitral Regurgitation?
    J Am Coll Cardiol. 2019;74:871-873.
    PubMed    


  180. ESSAYAGH B, Antoine C, Benfari G, Messika-Zeitoun D, et al
    Prognostic Implications of Left Atrial Enlargement in Degenerative Mitral Regurgitation.
    J Am Coll Cardiol. 2019;74:858-870.
    PubMed     Abstract available


  181. NESTELBERGER T, Boeddinghaus J, Wussler D, Twerenbold R, et al
    Predicting Major Adverse Events in Patients With Acute Myocardial Infarction.
    J Am Coll Cardiol. 2019;74:842-854.
    PubMed     Abstract available


    July 2019
  182. KIM JY, Kim SH
    Reply: Off-Label Use of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362-3363.
    PubMed    


  183. ZHOU Z
    Efficacy and Safety of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362.
    PubMed    


    June 2019
  184. DEFILIPPI C, Seliger S, Latta F, Peters M, et al
    High-Sensitivity Cardiac Troponin Assays Potentially Differentiate Acute From Chronic Myocardial Injury.
    J Am Coll Cardiol. 2019;73:2904-2905.
    PubMed    


    May 2019
  185. DEFERM S, Bertrand PB, Verbrugge FH, Verhaert D, et al
    Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:2465-2476.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: